For hemophilia and thalassemia, a new era of 'one-and-done' gene therapies has arrived.

MLA

Sheridan, Cormac. “For Hemophilia and Thalassemia, a New Era of ‘One-and-Done’ Gene Therapies Has Arrived.” Nature Biotechnology, vol. 40, no. 11, Nov. 2022, pp. 1531–33. EBSCOhost, https://doi.org/10.1038/s41587-022-01555-0.

APA

Sheridan, C. (2022). For hemophilia and thalassemia, a new era of “one-and-done” gene therapies has arrived. Nature Biotechnology, 40(11), 1531–1533. https://doi.org/10.1038/s41587-022-01555-0

Chicago

Sheridan, Cormac. 2022. “For Hemophilia and Thalassemia, a New Era of ‘One-and-Done’ Gene Therapies Has Arrived.” Nature Biotechnology 40 (11): 1531–33. doi:10.1038/s41587-022-01555-0.